All articles by Heidi Vella

Crystal clear: could unlocking proteins provide new cures for anxiety?

Earlier this year, a research team at Michigan State University (MSU) managed to reveal, for the first time, the crystal…
Draining cancer’s fuel tank

Cancer stem cells have long been the subject of intensive research. Since they were first identified, the scientific community has…
A new ERA for pulmonary arterial hypertension patients in England

Thanks to the recent approval of a new drug developed by Actelion, patients in England with life-threatening orphan disease pulmonary…
Boehringer to close manufacturing lab, losing 1,100 jobs

Boehringer Ingelheim GmbH has announced plans to shutdown its Ben Venue Laboratories unit by the end of the month, cutting…
GSK and Genmab seek alternative approval for leukaemia drug Arzerra

GlaxoSmithKline and Genmab A/S have announced the submission of leukaemia drug Arzerra to the European Medicines Agency (EMA) for a…

Aerial Biopharma announce positive Phase II results for narcolepsy drug

A new drug to treat excessive daytime sleepiness associated with narcolepsy has shown positive results from a phase 2b clinical…
Common blood pressure drug could help fight tumours

A common blood pressure drug marketed by Merck & Co could help fight cancer tumours, a recent study on mice…
UK’s cancer drug fund extended to 2016

A £200m-a-year cancer drugs fund due to expire next year will be extended until 2016, UK Prime Minister David Cameron…
Boehringer Ingelheim cancer drug shows positive results in Phase III trial

Boehringer Ingelheim's LUME-Lung 1 Phase III clinical trial of novel investigational compound nintedanib has provided a significant and clinically relevant…
UK cancer study group to co-fund research into new cancer treatment

The Cancer Research Technology Pioneer Fund CPF has announced it has chosen a study to develop a promising class of…